Major trial to look at whether Vitamin D can protect against Covid

Researchers seek more than 5,000 participants for study

Rory Sullivan
Tuesday 13 October 2020 18:58
Comments
A study will examine whether Vitamin protects against Covid-19. 
A study will examine whether Vitamin protects against Covid-19. 

A London university has launched a study to see whether vitamin D offers protection against Covid-19.

Researchers from Queen Mary University of London will run the “Coronavit trial” to work out whether increased vitamin D levels could lower the risk of respiratory infections including coronavirus.

The research project, which is funded by Barts Charity, hopes to attract more than 5,000 participants, who will each be sent vitamin D supplements and tests in the post.

Professor Adrian Martineau, the study’s lead researcher, said there is “mounting evidence that vitamin D might reduce the risk of respiratory infections”.

"Vitamin D deficiency is more common in older people, in people who are overweight, and in black and Asian people - all of the groups who are at increased risk of becoming very ill with Covid-19,” he added.

His colleague, Dr David Jolliffe, who is the trial’s principal investigator, said the study could potentially help the world tackle the pandemic.

"Vitamin D supplements are low in cost, low in risk and widely accessible; if proven effective, they could significantly aid our global fight against the virus,” he explained.

However, the National Institute for Health and Care Excellence (Nice) said in June that there was not sufficient evidence to conclude that vitamin D supplements protected people against coronavirus.

Vitamin D is often referred to as the “sunshine vitamin” because bodies create it when skin is exposed to sunlight. It helps to keep bones, teeth and muscles healthy by regulating calcium and phosphate levels.

Given there is less sunshine in winter and autumn in the UK, official guidance recommends that people take supplements for vitamin D between October and March.

Anyone over 16 living in the UK is eligible to take part in the Queen Mary University study as long as they do not currently take high doses of the vitamin.

Additional reporting from PA

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Join our new commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged in